Skip to main content
. 2018 May 24;32:84–92. doi: 10.1016/j.ebiom.2018.05.008

Fig. 1.

Fig. 1

Expression of PGE2 receptors in human and murine tumors. (a) Immunohistochemical staining of EP1-EP4 (DAB, brown staining) in primary human high-risk neuroblastoma tumors: MYCN-amplified and 11q-deleted (11q-), respectively. (b) Immunohistochemical analysis of EP1-EP4 in tumors from two different mouse models of neuroblastoma: a transgenic MYCN-driven model (tgTH-MYCN) and a xenograft model inoculated with the 11q-deleted human neuroblastoma cell line SK-N-AS (SK-N-AS xenograft). Sections were counterstained with Mayer's hematoxylin. Scale bars indicate 50 μm. (c) Dual labeling of PGE2 receptors, EP3 and EP4 (green), with neuroblastoma marker GD2 and CAF marker PDGFRβ (red) respectively in primary human neuroblastoma tumors. Sections were counterstained with nuclear dye Hoechst (blue).